Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR).

Chengappa Kavadichanda GanapathyVineeta ShobhaParasar GhoshAnupam WakhluDevender BairwaManju MohananRamya JanardanaGeetabali SircarRasmi Ranjan SahooSneha JosephVir Singh NegiDinesh KhannaPadmanabha Shenoy

Published in: Rheumatology advances in practice (2021)

Individuals with scleroderma in India have been affected during the pandemic owing to closure of hospital services, lack of transport, loss of jobs and the additional financial burden. Health-care providers should continue to educate patients to stay on their medications and encourage them to be vaccinated for COVID-19.

Keyphrases

systemic sclerosis
healthcare
end stage renal disease
ejection fraction
coronavirus disease
chronic kidney disease
sars cov
newly diagnosed
interstitial lung disease
peritoneal dialysis
primary care
emergency department
adverse drug
affordable care act